¿Cuál es la importancia de la diferenciación de células madre en los tratamientos con fibroblastos?
The science of skincare and regenerative aesthetic medicine have advanced significantly in recent decades, revealing the crucial role of cellular differentiation and fibroblasts, a subtype of mesenchymal stem cells (MSCs) responsible for dermal regeneration. These cells, known as the “architects of the skin,” are responsible for the production of collagen and elastin, two essential components for maintaining firmness, elasticity, and a healthy appearance (Wong, McGrath, & Navsaria 2007).
Mesenchymal cells and their differentiation into fibroblasts are closely connected both in their origin and their functions. MSCs are precursors that can become fibroblasts through mechanisms of cellular differentiation, and both cell types collaborate in the regeneration and repair of tissues.
Understanding this relationship, as well as the importance of cellular interactions and chemical signals in regulating the cellular differentiation of mesenchymal cells into fibroblasts, is fundamental for the development of advanced therapies and key applications in aesthetic and regenerative medicine.
What are mesenchymal cells?
Mesenchymal stem cells are undifferentiated or multipotent stem cells derived from the mesenchyme, the embryonic tissue that gives rise to various cell types. These cells are a promising tool in regenerative medicine due to their capacity for cellular differentiation and their ability to regenerate different types of damaged tissues.
MSCs have the capacity to differentiate into various cell types, including osteocytes (bone cells), chondrocytes (cartilage cells), adipocytes (fat cells), and fibroblasts (cells that build the extracellular matrix of the dermis) (Mengod, 2013) (Flores-Figueroa, 2016). Additionally, they can secrete growth factors or bioactive factors that promote tissue repair.
Once differentiated, fibroblasts produce collagen, elastin, and other components of the extracellular matrix, which are essential for maintaining the structure and function of tissues. They are also crucial in wound healing, as they migrate to the site of the injury and produce new collagen fibers to repair the damaged tissue.
How do stem cells differentiate into other cells?
According to various authors, “differentiation consists of certain genes being silenced throughout development (of the MSCs), such that the potentiality of the cells narrows until they end up belonging to a specific cell type, with a specific gene expression program” (Garzón-Perdomo, et al., 2017).
The cellular differentiation of MSCs is regulated through two main mechanisms: intracellular signaling pathways, which modulate the expression of specific genes through the activation of transcription factors that promote or inhibit differentiation toward a particular lineage, and transcription factors—proteins that bind to specific DNA sequences and regulate gene transcription (Sánchez & Lizcano 2018).
Furthermore, the capacity of MSCs to differentiate and perform their functions is influenced by various factors, including cellular communication, the microenvironment, and chemical signals.
Cellular communication in the differentiation of mesenchymal stem cells
MSCs rely on external signals to direct their differentiation. This communication occurs through a process known as paracrine signaling, where cells emit and receive chemical signals through soluble molecules, such as growth factors and cytokines. These signals influence the genetic activity of MSCs, guiding their differentiation toward a specific lineage (Meirelles, et al., 2009).
Effects of the microenvironment on the differentiation of mesenchymal stem cells
The niche where MSCs reside, known as the microenvironment, includes components of the extracellular matrix, other cells, and soluble factors, which together create an environment conducive to cellular differentiation. The rigidity of the substrate, for example, can determine whether an MSC differentiates into an osteocyte or an adipocyte. A more rigid environment tends to favor osteogenic differentiation, while a softer environment favors adipogenesis.
Importance of chemical signals in the differentiation of mesenchymal stem cells
Specific chemical signals, such as growth factors (TGF-β, BMPs, FGF) and cytokines, activate intracellular signaling pathways that regulate the expression of specific genes necessary for cellular differentiation. For example, transforming growth factor-beta (TGF-β) is known to induce differentiation into chondrocytes, while bone morphogenetic proteins (BMPs) are crucial for osteogenesis (Flores-Figueroa, 2016).
Applications in regenerative medicine and cell therapies
Detailed knowledge of how cellular interactions and chemical signals influence the differentiation of MSCs has significant applications in regenerative medicine:
Bone regeneration: MSCs can be used to treat bone defects by promoting osteogenesis. By manipulating the microenvironment and chemical signals, it is possible to direct the differentiation of mesenchymal cells toward the formation of new bone tissue.
Cartilage repair: Cartilage injuries, common in conditions such as osteoarthritis, can benefit from the capacity of mesenchymal cells to differentiate into chondrocytes. Therapies that use MSCs and specific growth factors can improve cartilage regeneration and reduce disease progression.
Treatment of degenerative diseases: MSCs also have potential in the treatment of degenerative diseases through the regeneration of damaged tissues. For example, in heart disease, they can differentiate into heart cells and contribute to the repair of damaged tissue.
Aesthetic treatments with fibroblasts: By better understanding the mechanisms of MSC differentiation, more effective and personalized treatments for skin rejuvenation can be developed. One of the most promising applications is the use of autologous fibroblasts, that is, fibroblasts derived from the patient themselves. These fibroblasts can be cultured in a laboratory and then reintroduced into the skin to notably multiply their effect.
Fcells: Pioneers in the use of autologous fibroblasts
At Fcells, we are the leading mesenchymal cell research laboratory in Latin America. We use advanced technologies that enable important medical applications for stem cells and their derivatives, such as treatment with autologous fibroblasts, an innovation that allows millions of these regenerative cells to be received directly into the skin.
If you are looking to get the most out of your own mesenchymal cells to preserve your beauty and the youthful appearance of your skin, call us and one of our advisors will refer you to one of the clinics in our network of experts in aesthetic medicine.
Related content: What are mesenchymal stem cells and what are they used for?
REFERENCES
Wong, T., McGrath, J. A., & Navsaria, H. (2007). The role of fibroblasts in tissue engineering and regeneration. British Journal of Dermatology, 156(6), 1149–1155
Mengod, R. M. S. (2013). Cultivo y diferenciación de células madre mesenquimales procedentes de tejido adiposo en el interior de matrices tridimensionales biodegradables. Estudio de la heterogeneidad, interacción celular y bioseguridad (Doctoral dissertation, University of Zaragoza). Supervised by M. T. Muiño Blanco. University of Zaragoza, Spain.
Garzón-Perdomo, Diana Katherine, De los Reyes, Lina María, & Turner, Liliana Francis. (2017). Metodologías utilizadas en la diferenciación de células madre mesenquimales a linaje neuronal. Acta Neurológica Colombiana, 33(4), 299-306.
Flores-Figueroa, Eugenia, Montesinos, Juan José, & Mayani, Héctor. (2006). Células troncales mesenquimales: historia, biología y aplicación clínica. Revista de investigación clínica, 58(5), 498-511. Accessed August 12, 2024.
Sánchez Márquez, P., & Révérend Lizcano, C. A. (2018). Factors of gene differentiation and its future in the treatment of osteoporosis: From adipogénesis to osteoblatogenesis, in the same way and in the opposite direction?. Revista Colombiana De Endocrinología, Diabetes &Amp; Metabolismo, 5(4), 21–25.
Meirelles, L.daS., Fontes, A. M., Covas, D. T., & Caplan, A. I. (2009). Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine & growth factor reviews, 20(5-6), 419–427.